Erytech Pharma SA Probability of Future Stock Price Finishing Over 0.91
| ERYPDelisted Stock | USD 0.78 0.04 4.88% |
Erytech |
Erytech Pharma Target Price Odds to finish over 0.91
The tendency of Erytech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 0.91 or more in 90 days |
| 0.78 | 90 days | 0.91 | about 41.78 |
Based on a normal probability distribution, the odds of Erytech Pharma to move over $ 0.91 or more in 90 days from now is about 41.78 (This Erytech Pharma SA probability density function shows the probability of Erytech Stock to fall within a particular range of prices over 90 days) . Probability of Erytech Pharma SA price to stay between its current price of $ 0.78 and $ 0.91 at the end of the 90-day period is about 45.52 .
Given the investment horizon of 90 days Erytech Pharma SA has a beta of -0.27 suggesting as returns on the benchmark increase, returns on holding Erytech Pharma are expected to decrease at a much lower rate. During a bear market, however, Erytech Pharma SA is likely to outperform the market. Additionally Erytech Pharma SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Erytech Pharma Price Density |
| Price |
Predictive Modules for Erytech Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Erytech Pharma SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Erytech Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Erytech Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Erytech Pharma is not an exception. The market had few large corrections towards the Erytech Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Erytech Pharma SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Erytech Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.05 | |
β | Beta against Dow Jones | -0.27 | |
σ | Overall volatility | 0.1 | |
Ir | Information ratio | -0.03 |
Erytech Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Erytech Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Erytech Pharma SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Erytech Pharma SA is not yet fully synchronised with the market data | |
| Erytech Pharma SA has some characteristics of a very speculative penny stock | |
| Erytech Pharma SA has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (228 K) with profit before overhead, payroll, taxes, and interest of 4.18 M. | |
| Erytech Pharma SA currently holds about 54.05 M in cash with (31.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Erytech Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Erytech Stock often depends not only on the future outlook of the current and potential Erytech Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Erytech Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31 M | |
| Cash And Short Term Investments | 38.8 M |
Erytech Pharma Technical Analysis
Erytech Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Erytech Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Erytech Pharma SA. In general, you should focus on analyzing Erytech Stock price patterns and their correlations with different microeconomic environments and drivers.
Erytech Pharma Predictive Forecast Models
Erytech Pharma's time-series forecasting models is one of many Erytech Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Erytech Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Erytech Pharma SA
Checking the ongoing alerts about Erytech Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Erytech Pharma SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Erytech Pharma SA is not yet fully synchronised with the market data | |
| Erytech Pharma SA has some characteristics of a very speculative penny stock | |
| Erytech Pharma SA has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (228 K) with profit before overhead, payroll, taxes, and interest of 4.18 M. | |
| Erytech Pharma SA currently holds about 54.05 M in cash with (31.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Erytech Stock
If you are still planning to invest in Erytech Pharma SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Erytech Pharma's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |